On the financial front, the micro-cap pharma stock has scripted a sharp turnaround, swinging from losses in financial year 2023-24 (FY24) to a profit in FY25, supported by a growth in its revenue.

The trends on Gift Nifty also indicate a gap-down start for the Indian benchmark index. The Gift Nifty was trading around 24,729 level, a discount of nearly 143 points from the Nifty futures’ previous ...

Amazon.com, Inc.'s Q2 impresses but shares dip on cautious Q3 outlook. Click for my updated look at AMZN stock and why I ...

Omnicell's service business is rapidly growing, now 22% of revenue, outpacing industry trends and supporting long-term upside ...

Overview AI-driven stocks have surged in value, but analysts believe they still hold long-term growth potential.Market enthusiasm is supported by strong fundame ...

U.S. stock futures rose on Thursday after ending on a mixed note on Wednesday. Futures of major benchmark indices were higher ...

Nebius is scheduled to report earnings for the second calendar quarter of 2025 on Aug. 7. Let's detail what investors should ...

In today’s dynamic stock market, monitoring Big Data and AI-driven insights is crucial for investors. Anil Singhvi highlights key market indicators such as increased volatility, influenced by global ...

Investing in the stock market doesn't have to cost you an arm and a leg. The Invesco QQQ Trust proves this point. It carries an expense ratio of just 0.20%. For a $10,000 investment, only $20 every ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

If the company’s core business continues growing at the current rate and its Superintelligence efforts gain traction, ...

The market witnesses the see-saw on Thursday due to Trump's 25% tariff on Indian goods and penalties for trade with Russia.